# A Phase I Study of LY3502970 in Healthy Participants

> **NCT06085482** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3502970
- **DRUG:** [14C]-LY3502970

## Key facts

- **NCT ID:** NCT06085482
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-19
- **Primary completion:** 2024-01-05
- **Final completion:** 2024-01-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085482, "A Phase I Study of LY3502970 in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06085482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*